Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $83.80, giving the company a market capitalization of 9.06B. It carries a P/E multiple of 192.17.
On 2026-11-03, Corcept Therapeutics(CORT) stock moved within a range of $80.92 to $84.06. With shares now at $83.80, the stock is trading +3.6% above its intraday low and -0.3% below the session's peak.
Trading volume for Corcept Therapeutics(CORT) stock has reached 674.57K, versus its average volume of 1.3M.
The stock's 52-week range extends from a low of $28.66 to a high of $126.38.
The stock's 52-week range extends from a low of $28.66 to a high of $126.38.
CORT News
Corcept Therapeutics reported positive Part A data from its Phase 2 BELLA trial in platinum-resistant ovarian cancer, where adding Lifyorli and bevacizumab to n...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.